USPTO serial 79140783
EMTEKO
Reviewed by CopyMark Law Group
Reg. 4693760Status 404
- Filing date
- Status date
- Registration date
- Mar 3, 2015
- Examiner
- FIORELLI, JOANNA ELISA-HOLGUI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EMTEKO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, pharmaceutical preparations for prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; sanitary products for medicine, namely, sanitary preparations for medical use; dietetic food and substances for medical use, namely, crackers and pasta, adapted for medical use, dietetic sugar substitutes for medical use; food for babies; food supplements for humans; medical plasters, materials for dressings, namely, gauze for dressings; material for dental fillings and dental impressions; disinfectants, namely, all-purpose disinfectants, disinfectants for hygienic purposes, disinfectants for hygiene purposes, disinfectants for sanitary purposes, disinfectants for contact lenses; preparations for destroying vermin; tobacco-free cigarettes for medical purposes; antibiotics; vaccines; wadding for medical use; sea water for medicinal bathing; mineral waters for medical use; thermal water, namely, water from hot springs for medicinal bathing; mustard plasters in the nature of medical plasters; mud for baths, namely, herbal mud packs for therapeutic purposes; medicinal mud for therapeutic purposes; cod liver oil; iodine for pharmaceutical use; wart pencils for removing warts; bunion pads; callus removing preparations for medical purposes, namely, products for calluses in the nature of callus creams, sprays, ointments, and gels; anti-rheumatism rings; candy for pharmaceutical use; adhesive plaster for medical purposes; ointments for pharmaceutical use in the nature of mercurial ointments for pharmaceutical use, antibiotic ointments, anti-inflammatory ointments, hemorrhoidal ointments, medicated ointments for treating dermatological conditions, anti-itch ointments, medicated sunburn ointments, mentholated ointment for medical use; frostbite salve for pharmaceutical use; gauze for dressings; anti-horsefly oils in the nature of insect repellants; medicinal oils; medical dressings; medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medicines for dental use; filled first-aid boxes; medicinal drinks; malted milk beverages for medical use; narcotics in the nature of prescription synthetic narcotics; antiseptic preparations in the nature of tinctures for medical purposes, namely, tinctures of iodine, mercurial and alcohol tinctures for medical use; sanitary panties; absorbent underpants for incontinence; sanitary napkins for incontinence; hydrogen peroxide for medical purposes; plasters, namely, medical plasters, corn plasters, court plasters; eyepatches for medical purposes; compresses, namely, eye compresses, medicated compresses; surgical dressings; breast-nursing pads; medicated hair care preparations in the nature of pomades for medical use; belts for sanitary towels; sanitary tampons; bacterial preparations for medical use; bacteriological preparations for medical use; balms for medical use; albuminous preparations for medical use in the nature of albumin dietary supplements; biological preparations for medical use, namely, for the treatment of cancer, HIV, and for the regeneration of organs and tissue; bismuth preparations for pharmaceutical use; vitamin preparations; diagnostic preparations for medical use; hemorrhoid treatment preparations; preparations to facilitate teething in the nature of oral analgesics; products for the treatment of burns, namely, burn dressings, burn relief medication, skin grafts for the treatment of burns; sanitary sterilizing preparations; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for skin care; contact lens cleaning preparations; therapeutic medicated bath preparations; medicinal hair growth preparations; preparations of trace elements in the nature of vitamins and mineral supplements for human consumption; sulfonamide preparations; sunburn preparations for pharmaceutical use; enzyme preparations for medical use; pharmaceutical preparations for use in chemotherapy; chemical preparations for medical purposes, namely, for the diagnosis of pregnancy; chilblain preparations; vaginal washes; contact lens solutions; hygienic bandages, namely, bandages for skin wounds, ear bandages, menstruation bandages; suppositories; soporifics; mineral water salts for medical purposes; salts for medical purposes in the nature of medicated bath salts, mineral and sodium salts for medical purposes; anesthetics in the nature of general anesthetics, local anesthetics, topical anesthetics; antiseptics; analgesics; medicines for the treatment of intestinal worms, namely, vermifuges; appetite suppressants for medical use; medical preparations for slimming purposes; febrifuges; depuratives for the body; migraine treatment preparations; remedies for perspiration, namely, prescription medicines for the treatment of excessive perspiration; chemical contraceptives, namely, contraceptive preparations, injectable contraceptives, and contraceptive foams; anti-parasitic preparations; purgatives; nerviness, namely, pharmaceutical preparations for peripheral nervous system, central nervous system stimulants; tranquillizers; digestives for pharmaceutical use; medicinal herbs; enzymes for medical use; ferments for pharmaceutical use; herbal teas for medicinal purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 18, 2024 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 18, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 16, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 28, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 6, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 6, 2022 | INPC | INVALIDATION PROCESSED | — |
| May 17, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 17, 2021 | C71T | CANCELLED SECTION 71 | — |
| Mar 3, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 15, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 14, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 14, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 3, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 3, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 16, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 16, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 3, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 26, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 12, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 5, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 14, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 14, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 14, 2014 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 11, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 11, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 28, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jul 14, 2014 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 14, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 2, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 14, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 14, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 14, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 13, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 7, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 3, 2014 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jan 2, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |